rinri stem cell hearing loss treatment

Rinri Therapeutics Raises £10 million to Advance Stem Cell Therapy Hearing Loss Treatment

SHEFFIELD, ENGLAND — Rinri Therapeutics, a biotechnology company developing a novel stem cell therapy to restore hearing, today announces that it has raised a total of £10 million (~$14M USD) from existing investors Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures and BioCity alongside the UK Government Future Fund. The proceeds will support the development of…

Read More
rinri hearing loss therapy

Rinri Therapeutics Secures $1.8M Seed Funding to Advance Novel Hearing Regeneration Therapy

SHEFFIELD, UNITED KINGDOM — Rinri Therapeutics, a biotechnology company developing a novel cell-based therapy to restore hearing, announced today that it successfully secured £1.4 million (approximately $1.8M USD) in seed funding. The financing, which was co-led by Boehringer Ingelheim Venture Fund and UCB Ventures and joined by BioCity, will support the ongoing growth of the…

Read More